About Brain Stimulation

Brain Stimulation AB is a Swedish SME started in 2011 with the aim to provide an efficient assessment and rehabilitation after stroke and traumatic brain injuries. Exploiting brain plasticity results from research within a new concept of rehabilitation and diagnosis of cognitive impairments and disability of attention in stroke patients (Spatial Neglect). We address the global challenge of rehabilitating need for cognitive and upper limb impairments from Stroke, Dementia, Traumatic Brain Injuries, Parkinson and other degenerative brain diseases by using Enriched Rehabilitation.

Cognitive impairments as in the Neglect Syndrome is not easily discovered using traditional tests nor treated in suitable way or time and the normal hospital stay is too short to reach effect from training. Our innovative products meet the need of early detection and diagnosis as well as efficient rehabilitation of patients in clinics, rehab-facilities and at home.

Our New products using Mixed Reality will provide task-specific rehabilitation and support E-health- solutions, on-line support. The Early supported Discharge to home environment, is positive for both patient and healthcare but there must be an access to task specific training.

Management and employees

Helena Fordell, CEO, MD, PhD, Neurologist and scientist at Umeå University Hospital. Board member and founder of Brain Stimulations AB. More than 20 years’ experience of rehabilitation of stroke patients. Dr Fordell is a clinical expert and neuroscientist with an extensive international network of expertise in the field.

Derny Häggström, Chairman of Board, Entrepreneur and founder of Oryx AB (developing VR- simulators for heavy machines used in construction, forestry, mining and cargo) with 20 years’ experience of successful commercialization, internationalization and business development.

Fredrik Jonsson, CMO, Specialist within sales and marketing of MedTech products on a global market. Experience within start-up, entrepreneurship, business and product development.  B.Sc Industrial Design and engineering

Emil Palm , M.Sc, R&D, Expertise in Programming, Technical- and product- Development. Experience within start-up, Medtech E-health, product management and quality.  M.Sc in Computer science

Birgitta Johansson, Occupational therapist, Thirty years’ experience as clinician occupational therapist and specialist within the usage, development and implementation of new technologies to improve neurorehabilitation

Investors

We are looking for investors and collaboration partners to enable and execute developments and commercialization’s of existing and new products according to our business plan and strategy.

Technology and Pipeline

Ongoing activities and development RehAtt® AR

  • RehAtt® AR initial Proof of concept performed 2018-2019, ongoing activities and evaluation, validation for Home Reahabilitation.
  • International Multi-center study and validation, aim to provide multiple publications (RehAtt® AR)
  • Investors and partners, onboarding
  • CE-approval and market launch RehAtt®AR, aim 2022
  • Increased market, home care and E-health
  • Continues improvements of already CE-approved RehAtt®VR-DiSTRO and RehAtt®VR

The company has funding from Umeå Biotech Incubator AB and BIO-X program from Uppsala BIO. It has also support from Biotech Umeå at Uminova Innovation AB and Bio-X. Recently received EU SME-1.

The owners of the company are:

  • The founder, Dr. Helena Fordell,
  • Uminova Holding
  • ALMI Invest
  • Chairman, Derny Häggström
  • Independent Business Partners, Per-Ulrik Wier

bio-x     Vinnova_RGB_ram_webb   Almi Invest      umea-biotech-incubator-brain-stimulation

biotech-umea-brain-stimulation  umea-universitet-brain-stimulation

 

Comments are closed